Empagliflozin as add‐on to metformin in people with Type 2 diabetes

Abstract

In people with Type 2 diabetes, empagliflozin 10 mg and 25 mg given as add-on to metformin for 76 weeks were well tolerated and led to sustained reductions in HbA1c , weight and systolic blood pressure.